monitoring disease in high-risk mm: euroflow with mass spectrometry
Published 4 years ago • 130 plays • Length 2:12Download video MP4
Download video MP3
Similar videos
-
4:22
mass spectrometry and response monitoring in multiple myeloma
-
2:40
advantages & uses of mass spectrometry in the diagnosis and monitoring of multiple myeloma
-
1:55
mrd monitoring for myeloma
-
1:05
clonotypic mass spectrometry with easym assay for mrd detection in multiple myeloma
-
1:57
using molecular abnormalities for risk stratification in multiple myeloma at the time of diagnosis
-
3:23
molecular characteristics associated with increased risk of disease progression in smm
-
3:48
trials of interest in newly diagnosed myeloma presented at ims 2024
-
6:23
results of maintenance therapy in high-risk myeloma patients | ajay nooka, md, mph, facp | asco 2023
-
4:07
haemodynamic monitoring | medical case discussion
-
4:56
imeta | tiger: tumor immunotherapy gene expression data analysis r package
-
2:20
ultra high-risk myeloma
-
2:00
advancing mrd monitoring in myeloma
-
8:13
treatment strategies for high-risk mm
-
2:23
the use of immunophenotyping to assess minimal residual disease (mrd) in multiple myeloma
-
5:18
response monitoring in multiple myeloma
-
8:42
assessing mrd in multiple myeloma
-
1:46
ctc whole-genome sequencing vs fish to monitor the emergence of multiple myeloma high-risk subclones
-
1:30
screening high-risk individuals for mm
-
9:41
the i4mds consortium and immune monitoring in mds
-
1:36
identification of high-risk disease using molecular profiling by mymap
-
3:25
identifying & monitoring patients with high-risk clonal hematopoiesis